Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies
A Strzelczyk, S Schubert-Bast - CNS drugs, 2022 - Springer
The developmental and epileptic encephalopathies encompass a group of rare syndromes
characterised by severe drug-resistant epilepsy with onset in childhood and significant …
characterised by severe drug-resistant epilepsy with onset in childhood and significant …
The tuberous sclerosis complex
PB Crino, KL Nathanson… - New England Journal of …, 2006 - Mass Medical Soc
The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder
affecting children and adults, results from mutations in one of two genes, TSC1 (encoding …
affecting children and adults, results from mutations in one of two genes, TSC1 (encoding …
Recent advances in pharmacotherapy for epilepsy
AW Pong, KJ Xu, P Klein - Current opinion in neurology, 2023 - journals.lww.com
Recent advances in pharmacotherapy for epilepsy : Current Opinion in Neurology Recent
advances in pharmacotherapy for epilepsy : Current Opinion in Neurology Log in or Register …
advances in pharmacotherapy for epilepsy : Current Opinion in Neurology Log in or Register …
mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus
X Zhao, S Wang, S Wang, J Xie, D Cui - Clinical Immunology, 2022 - Elsevier
Systemic lupus erythematosus (SLE) is a typical autoimmune disease characterized by
multiorgan involvement and marked variability in clinical presentation. SLE pathogenesis …
multiorgan involvement and marked variability in clinical presentation. SLE pathogenesis …
[HTML][HTML] Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus
R Previtali, G Prontera, E Alfei, L Nespoli… - Pharmacological …, 2023 - Elsevier
Tuberous sclerosis complex is an autosomal dominant disease characterised by abnormal
cell proliferation and differentiation that affects multiple organs and can lead to the growth of …
cell proliferation and differentiation that affects multiple organs and can lead to the growth of …
Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures
DS Reddy, RH Mbilinyi, S Ramakrishnan - Experimental Neurology, 2023 - Elsevier
Presently there is no drug therapy for curing epilepsy. Despite many advancements in
epilepsy research, nearly 30% of people with epilepsy remain refractory to current …
epilepsy research, nearly 30% of people with epilepsy remain refractory to current …
Treatment-resistant epilepsy and tuberous sclerosis complex: treatment, maintenance, and future directions
Tuberous sclerosis complex (TSC) is a neurogenetic disorder that affects multiple organ
systems, including the heart, kidneys, eyes, skin, and central nervous system. The …
systems, including the heart, kidneys, eyes, skin, and central nervous system. The …
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic
H Jyonouchi - Frontiers in Psychiatry, 2024 - frontiersin.org
Autism spectrum disorder (ASD1) is a behaviorally defined syndrome encompassing a
markedly heterogeneous patient population. Many ASD subjects fail to respond to the 1st …
markedly heterogeneous patient population. Many ASD subjects fail to respond to the 1st …
Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: a multicentre cohort study from Germany
LM Willems, S Schubert-Bast, J Grau… - European Journal of …, 2021 - Elsevier
Objective This study aimed to measure health-related quality of life (HRQOL) in children and
adolescents with tuberous sclerosis complex (TSC) and quality of life (QOL) and depressive …
adolescents with tuberous sclerosis complex (TSC) and quality of life (QOL) and depressive …
[HTML][HTML] Epidemiology of focal onset seizures in children aged> 1 month to 4 years in Europe, United States, and Canada: A literature review
S Schubert-Bast, M Kaur, L Joeres, N Foskett… - … : European Journal of …, 2023 - Elsevier
The present study aims to report the currently available epidemiology of focal onset seizures
in children aged> 1 month to 4 years with the help of a literature review. The terms …
in children aged> 1 month to 4 years with the help of a literature review. The terms …